Innovative technologies in the management of diabetes mellitus: prevention of hypoglycemia

One of the strategies for preventing hypoglycemia, along with structured patient education and the use of modern hypoglycemic agents, is self-control of glycemia with the achievement of individual therapeutic goals. Frequently recurring hypoglycemic episodes are associated with impaired recognition of hypoglycemia and increase the risk of severe hypoglycemia up to six times. Prevention of the development of severe hypoglycemia may be of key importance for the prevention of adverse cardiovascular events and the risk of sudden death in patients with diabetes mellitus. Repeated hypoglycemic episodes can lead to impaired recognition of hypoglycemia, as a result of which a lower blood glucose level is necessary for the development of clinical symptoms of hypoglycemia. The use of individual glucose meters is currently relevant, despite the active introduction into clinical practice of continuous monitoring of glycemia and flash monitoring. ccording to the Russian “Algorithms of specialized medical care for patients with diabetes mellitus”, patients are recommended to conduct self-monitoring using individual glucose meters at least 4 times a day when using continuous monitoring of glycemia in real time and at least 2 times a day when using flash monitoring of glycemia to assess accuracy and / or calibration monitoring data and in order to resolve the issue of correction of ongoing therapy. The desire for strict and adequate self-control dictates the need to use the latest means of glycemia control – intelligent glucose meters with high accuracy, ease of  use and reliability of  blood glucose measurements. The introduction of intelligent technologies – “smart” glucose meters using a mobile application, with the functions of “no coding”, “second chance”, data transmission to the attending physician – makes it possible to carry out remote monitoring, providing more effective management of diabetes mellitus.

1. Дедов И.И., Шестакова М.В., Майоров А.Ю., Мокрышева Н.Г., Викулова О.К., Галстян Г.Р. и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Сахарный диабет. 2021;24(1S):1–148. https://doi.org/10.14341/DM12802. Dedov I.I., Shestakova M.V., Mayorov A.Yu., Mokrysheva N.G., Vikulova O.K., Galstyan G.R. et al. Standards of specialized diabetes care. Diabetes Mellitus. 2021;24(1S):1–148. (In Russ.) https://doi.org/10.14341/DM12802.

2. Светлова О.В., Гурьева И.В., Савченко Л.С. Современные возможности самоконтроля: Новая эра эффективного управления сахарным диабетом. Медицинский совет. 2019;(4):30–33. https://doi.org/10.21518/2079- 701X-2019-4-30-33. Svetlova O.V., Guryeva I.V., Savchenko L.S. Modern strategies for self-monitoring: new era of effective diabetes management. Meditsinskiy Sovet. 2019;(4):30–33. (In Russ.) https://doi.org/10.21518/2079-701X-2019-4-30-33.

3. Bednarik P., Moheet A.A., Grohn H., Kumar A.F., Eberly L.E., Seaquist E.R., Mangia S. Type 1 Diabetes and Impaired Awareness of Hypoglycemia Are Associated with Reduced Brain Gray Matter Volumes. Front Neurosci. 2017;(11):529. https://doi.org/10.3389/fnins.2017.00529.

4. Урлаева И.В. Гипогликемия – барьер в достижении гликемического контроля. Значимость самоконтроля гликемии. Клинический разбор в общей медицине. 2021;(7):40–44. https://doi.org/10.47407/kr2021.2.7.00087. Urlaeva I.V. Hypoglycemia, an obstacle to achieving glycemic control. Importance of blood glucose self-monitoring. Clinical Review for General Practice. 2021;(7):40–44. (In Russ.) https://doi.org/10.47407/kr2021.2.7.00087.

5. Светлова О.В., Гурьева И.В. Новый уровень технологий – новый уровень самоконтроля в управлении сахарным диабетом. Медицинский совет. 2015;(7):48–50. Режим доступа: https://www.med-sovet.pro/jour/article/ view/210/210. Svetlova O.V., Guryeva I.V. A new level of technology is a new level of self-monitoring in the management of diabetes. Meditsinskiy Sovet. 2015;(7):48–50. (In Russ.) Available at: https://www.med-sovet.pro/jour/article/view/210/210.

6. Diabetes Control and Complications Trial Research Group, Nathan D.M., Genuth S., Lachin J., Cleary P., Crofford O. et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986. https://doi.org/10.1056/NEJM199309303291401.

7. Ratzki-Leewing A., Harris S.B., Mequanint S., Reichert S.M., Brown J.B., Black J.E., Ryan B.L. Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada. BMJ Open Diabetes Res Care. 2018;6(1):e000503. https://doi.org/10.1136/bmjdrc-2017-000503.

8. Бирюкова Е.В. Современные возможности самоконтроля гликемии в лечении сахарного диабета. Consilium Medicum. 2019;21(10):117–121. Режим доступа: https://journals.eco-vector.com/2075-1753/article/view/95257. Biryukova E.V. Current possibilities of glycemic self-control in the treatment of diabetes mellitus. Consilium Medicum. 2019;21(10):117–121. (In Russ.) Available at: https://journals.eco-vector.com/2075-1753/article/view/95257.

9. Климонтов В.В. Нарушение распознавания гипогликемии при сахарном диабете: эпидемиология, механизмы развития, терапевтические подходы. Сахарный диабет. 2018;21(6):513–523. https://doi.org/10.14341/DM9597. Klimontov V.V. Impaired hypoglycemia awareness in diabetes: epidemiology, mechanisms and therapeutic approaches. Diabetes Mellitus. 2018;21(6):513–523. (In Russ.) https://doi.org/10.14341/DM9597.

10. Cariou B., Fontaine P., Eschwege E., Lievre M., Gouet D., Madani S. et al. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study. Diabetes Metab. 2015;41(2):116–125. https://doi.org/10.1016/j.diabet.2014.10.007.

11. Geddes J., Schopman J.E., Zammitt N.N., Frier B.M. Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med. 2008;25(4):501–504. https://doi.org/10.1111/j.1464-5491.2008.02413.x.

12. Hendrieckx C., Hagger V., Jenkins A., Skinner T.C., Pouwer F., Speight J. Severe hypoglycemia, impaired awareness of hypoglycemia, and self-monitoring in adults with type 1 diabetes: Results from Diabetes MILES-Australia. J Diabetes Complications. 2017;31(3):577–582. https://doi.org/10.1016/j. jdiacomp.2016.11.013.

13. Conget I., Ávila D., Giménez M., Quiros C., Salaverria V., Dueñas B. Impaired awareness of hypoglycaemia in subjects with type 1 diabetes. Results of an online survey in a diabetes web site. Endocrinol Nutr. 2016;63(3):121–125. https://doi.org/10.1016/j.endonu.2015.11.003.

14. Henriksen M.M., Faerch L., Thorsteinsson B., Pedersen-Bjergaard U. LongTerm Prediction of Severe Hypoglycemia in Type 1 Diabetes: Is It Really Possible? J Diabetes Sci Technol. 2016;10(6):1230–1235. https://doi.org/10.1177/ 1932296816664745.

15. Rickels M.R., Peleckis A.J., Dalton-Bakes C., Naji J.R., Ran N.A., Nguyen H.L. et al. Continuous Glucose Monitoring for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes. J Clin Endocrinol Metab. 2018;103(1):105–114. https://doi.org/10.1210/jc.2017-01516.

16. Kempler P., Váradi A., Tamás G. Autonomic neuropathy in newly diagnosed diabetes mellitus. Diabetes Care. 1993;16(5):848–849. https://doi.org/10.2337/ diacare.16.5.848.

17. Шестакова М.В., Викулова О.К., Исаков М.А., Дедов И.И. Сахарный диабет и COVID-19: анализ клинических исходов по данным регистра сахарного диабета Российской Федерации. Проблемы эндокринологии. 2020;66(1):35–46. https://doi.org/10.14341/probl12458. Shestakova M.V., Vikulova O.K., Isakov M.А., Dedov I.I. Diabetes and COVID-19: analysis of the clinical outcomes according to the data of the russian diabetes registry. Problemy Endokrinologii. 2020;66(1):35–46. (In Russ.) https://doi.org/10.14341/probl12458.

18. Трухан Д.И. Актуальность самоконтроля уровня глюкозы крови в аспекте профилактики сердечно-сосудистых осложнений у больных сахарным диабетом. Медицинский совет. 2021;(14):104–109. https://doi.org/10.21518/2079- 701X-2021-14-104-109. Trukhan D.I. Relevance of self-control of blood glucose in the aspect of prevention of cardiovascular complications in patients with diabetes mellitus. Meditsinskiy Sovet. 2021;(14):104–109. (In Russ.) https://doi.org/10.21518/2079-701X-2021-14-104-109.

19. Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Самоконтроль гликемии – неотъемлемый компонент лечения сахарного диабета. Медицинский cовет. 2013;(1–2):90–97. Режим доступа: https://www.med-sovet.pro/jour/ article/view/847. Mayorov A.Yu., Melnikova O.G., Filippov Yu.I. Self-monitoring of blood glucose: an indispensable component of diabetes treatment. Meditsinskiy Sovet. 2013;(1–2):90–97. (In Russ.) Available at: https://www.med-sovet.pro/jour/ article/view/847.

20. Cryer P.E. Mechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes. Diabetes. 2005;54(12):3592–3601. https://doi.org/10.2337/diabetes.54.12.3592.

21. Шестакова М.В., Майоров А.Ю., Филиппов Ю.И., Ибрагимова Л.И., Пекарева Е.В., Лаптев Д.Н., Глазунова А.М. Федеральные клинические рекомендации по помповой инсулинотерапии и непрерывному мониторированию гликемии у больных сахарным диабетом. ПРОЕКТ. Проблемы эндокринологии. 2015;61(6):55–78. https://doi.org/10.14341/ probl201561655-78. Shestakova M.V., Mayorov A.Yu., Philippov Yu.I., Ibragimova L.I., Pekareva E.V., Laptev D.N., Glazunova A.M. Russian national guidelines on insulin pump therapy and continuous glucose monitoring for diabetes mellitus patients. DRAFT. Problemy Endokrinologii. 2015;61(6):55–78. (In Russ.) https://doi.org/10.14341/probl201561655-78.

22. Mannucci E., Antenore A., Giorgino F., Scavini M. Effects of Structured Versus Unstructured Self-Monitoring of Blood Glucose on Glucose Control in Patients With Non-insulin-treated Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. J Diabetes Sci Technol. 2018;12(1):183–189. https://doi.org/10.1177/1932296817719290.

23. Bailey T.S., Wallace J.F., Pardo S., Warchal-Windham M.E., Harrison B., Morin R., Christiansen M. Accuracy and User Performance Evaluation of a New, Wirelessenabled Blood Glucose Monitoring System That Links to a Smart Mobile Device. J Diabetes Sci Technol. 2017;11(4):736–743. https://doi.org/10.1177/ 1932296816680829.

24. Моругова Т.В., Шестакова М.В. Индивидуальные и госпитальные глюкометры: баланс между несомненной пользой и безопасностью. Consilium Medicum. 2014;4(16):19–22. Режим доступа: https://journals.eco-vector. com/2075-1753/article/view/94005. Morugova T.V., Shestakova M.V. Individual and hospital blood glucose meters: undoubted benefit-risk balance. Consilium Medicum. 2014;4(16):19–22. (In Russ.) Available at: https://journals.eco-vector. com/2075-1753/article/view/94005.

25. Самойлова Ю.Г., Кошмелева М.В., Олейник О.А., Трифонова Е.И., Качанов Д.А., Муталими В.Э. Осознанный самоконтроль гликемии в реальной клинической практике как доступный инструмент для достижения компенсации сахарного диабета: пилотное исследование. Медицинский совет. 2023;17(1):82–88. https://doi.org/10.21518/ms2023-038. Samoilova I.G., Koshmeleva M.V., Oleynik O.A., Trifonova E.I., Kachanov D.A., Mutalimi V.E. Self-monitoring with a home glucometer as a reliable method for controlling for diabetes mellitus type 1: pilot study. Meditsinskiy Sovet. 2023;17(1):82–88. (In Russ.) https://doi.org/10.21518/ms2023-038.

26. Wiegers E.C., Becker K.M., Rooijackers H.M., von Samson-Himmelstjerna F.C., Tack C.J. et al. Cerebral blood flow response to hypoglycemia is altered in patients with type 1 diabetes and impaired awareness of hypoglycemia. J Cereb Blood Flow Metab. 2017;37(6):1994–2001. https://doi.org/10.1177/ 0271678X16658914.

27. Davis I.C., Ahmadizadeh I., Randell J., Younk L., Davis S.N. Understanding the impact of hypoglycemia on the cardiovascular system. Expert Rev Endocrinol Metab. 2017;12(1):21–33. https://doi.org/10.1080/17446651.2017.1275960.

28. Sommerfield A.J., Wilkinson I.B., Webb D.J., Frier B.M. Vessel wall stiffness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia. Am J Physiol Endocrinol Metab. 2007;293(5):E1274-E1279. https://doi.org/10.1080/17446651.2017.1275960.